Professor Emmanouil Karteris
Professor in Biomedical Sciences

Research area(s)

Professor Karteris has a long standing interest in mTOR signalling with emphasis in reproductive endocrinology and ovarian cancer. His lab is also active in the field of biomarker development using liquid biopsies. Dr Karteris has a recognized publication record in receptor biochemistry and cell signalling. He has published 104 manuscripts, presented over 100 research abstracts in leading national and international conferences.  Many of these papers are generating a strong and influential impact not only to the biomedical field (h index; 36) but also to the society as they deal with topical issues such as effects of stress during pregnancy. Moreover Professor Karteris has established collaborations with leading authorities in their fields and has been successful in obtaining research grants at national and international level. For more information visit www.cbcel.org

Research Interests

• Role of endocrine disrupting chemicals (EDCs), myokines and novel hormones in the fetal-placental unit
• Detection and characterisation of circulating tumour cells
• Use of liquid biopsies as cancer biomargers of diagnostic and prognostic value
• Development of fetal-placental 3D cultures as a screening platform for EDCs and hormones

Project details

(Most recent)

• Asthma Lung UK (2022-2026): Biomarker development for mesothelioma (£377,000, co-I)
• GRACE Charity (2021-2025): Role of asprosin in endometrial cancer (£15,000)
• CRUK (2018-2021): TRANS CeNtuRIOn Clinical Trial  (£193,845, co-I)